Most medical device manufacturers are launching new product in the US first, upending a decades-long tradition of companies going to Europe first for a CE mark.
Device Makers Are Bucking Decades-Long Trend Of Launching Products In EU. Here’s Why
Study finds more device makers are bringing new products to the US first
In this Medtech Insight Q&A, two UCLA-backed study authors argue that the US FDA “has emerged as the global regulatory agency most successful in promoting access to novel medtech products, especially digitally enabled or software-driven ones.”
![Interview](https://insights.citeline.com/resizer/v2/KTHUVRS2DZKFVMWKDBBSHV32ZM.jpg?smart=true&auth=666919b63b10e4b375cf97ea355ec0cb84421386fe8d4d142ef7ff5b7d7efb29&width=700&height=394)
More from Regulation
As the EU seeks to refine its medtech regulations, the advantages of the global Medical Device Single Audit Program are increasingly highlighted. Industry leaders are now urging authorities to take decisive action.
A flurry of firings as part of the Trump administration’s pledge to shrink the federal government hit the FDA over the weekend. While the exact number of staff let go is unclear, the agency’s device center took the brunt of it.
The latest list includes a new EU document in the wings that addresses the designation of medtech notified bodies under the AI Act.
A federal judge granted Doctors for America’s motion for a temporary restraining order directing the FDA and CDC to restore information removed from the agencies’ websites to comply with a presidential executive order targeting “gender ideology extremism.”
More from Policy & Regulation
Medical device recalls exceeded 1,000 in 2024, according to a recently published recall index report from Sedgwick. More than 10% of those recalls were class I, the FDA’s most serious category.
Boston Scientific has integrated cardiac mapping and pulsed field ablation into a single catheter with the newly EU-approved Farawave Nav Ablation Catheter. Faraview Software also receives CE marking, allowing for visualization of catheter placement when delivering therapy.
The 12 initial awards, which total almost $100m, are part of an ongoing program to develop a high-tech mobile hospital that can reach patients with limited access to health care.